234 related articles for article (PubMed ID: 11284462)
21. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
Ashcroft DM; Millson D
Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
[TBL] [Abstract][Full Text] [Related]
22. The scientific basis of medication choice in symptomatic migraine treatment.
Goadsby PJ
Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S20-6. PubMed ID: 10563229
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
Ahrens SP; Farmer MV; Williams DL; Willoughby E; Jiang K; Block GA; Visser WH
Cephalalgia; 1999 Jun; 19(5):525-30. PubMed ID: 10403069
[TBL] [Abstract][Full Text] [Related]
24. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
Solomon S; Frishberg B; Hu XH; Markson L; Berger M
Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
[TBL] [Abstract][Full Text] [Related]
25. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
[TBL] [Abstract][Full Text] [Related]
26. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
[TBL] [Abstract][Full Text] [Related]
27. Treatment of migraine with rizatriptan: when to take the medication.
Hu XH; Raskin NH; Cowan R; Markson LE; Berger ML;
Headache; 2002 Jan; 42(1):16-20. PubMed ID: 12005270
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks.
Müller T; Lohse L
Clin Neuropharmacol; 2011; 34(6):206-9. PubMed ID: 21996647
[TBL] [Abstract][Full Text] [Related]
29. WITHDRAWN: Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD002915. PubMed ID: 22336784
[TBL] [Abstract][Full Text] [Related]
30. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.
Cady RK; Martin VT; Géraud G; Rodgers A; Zhang Y; Ho AP; Hustad CM; Ho TP; Connor KM; Ramsey KE
Headache; 2009 May; 49(5):687-96. PubMed ID: 19472447
[TBL] [Abstract][Full Text] [Related]
31. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
Pascual J; Fité B; López-Gil A
Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
[TBL] [Abstract][Full Text] [Related]
32. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
33. Rizatriptan: an update of its use in the management of migraine.
Wellington K; Plosker GL
Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups.
Block GA; Goldstein J; Polis A; Reines SA; Smith ME
Headache; 1998; 38(10):764-71. PubMed ID: 11284464
[TBL] [Abstract][Full Text] [Related]
35. Spotlight on rizatriptan in migraine.
Wellington K; Jarvis B
CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863
[TBL] [Abstract][Full Text] [Related]
36. A randomized trial of rizatriptan in migraine attacks in children.
Ahonen K; Hämäläinen ML; Eerola M; Hoppu K
Neurology; 2006 Oct; 67(7):1135-40. PubMed ID: 16943370
[TBL] [Abstract][Full Text] [Related]
37. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
[TBL] [Abstract][Full Text] [Related]
38. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
39. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
40. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.
Lipton RB; McGinley JS; Shulman KJ; Wirth RJ; Buse DC
Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
